c ebpalpha and hepatic lipid Item - Depicted pathway for the exacerbated steatosis caused by combined treatment. - Public Library of Science JCI - Hepatocyte-specific CCAAT/enhancer binding
JCI Hepatocyte specific CCAAT enhancer binding protein restricts liver fibrosis progression A novel C EBPmiR 335 5pPRKAA2 regulatory axis drives hepatic lipid accumulation in MASLD Scientific Reports High dietary Fructose Drives Metabolic Dysfunction Associated Steatotic Liver Disease via Activating ubiquitin specific peptidase 2 11 hydroxysteroid dehydrogenase type 1 Pathway in Mice Crosstalk between Lipids and Non Alcoholic Fatty Liver Disease
Pay in 4 interest-free payments of $6.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



